Detox pathways can slow down without adequate B12, leading to increased fatigue, hormonal imbalance and sluggish digestion
Improvement in enthesitis, however, was statistically greater for both doses of golimumab at 14 and 24 weeks when assessed with the Maastricht Ankylosing Spondylitis Entheses Score (MASES) enthesitis index
[30]Current Patent Assignee: NICOX - US5703073, 1997, A
By replenishing NAD+ levels, this treatment helps combat fatigue, improve cognitive function, and slow the effects of aging
Ultimately, these series of reactions will activate the apoptotic pathways 33,34 (Figure 4)
It is a clinically validated, FDA-approved melanocortin receptor agonist with a robust preclinical and clinical research base supporting its distinct mechanism and unique application domain